2D3V,1OW0,2GI7,1G0X,1P6F,1OLL


Conserved Protein Domain Family
IgC2_D1_LILR_KIR_like

?
cd05751: IgC2_D1_LILR_KIR_like 
First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILRs), Natural killer inhibitory receptors (KIRs) and similar domains; member of Immunoglobulin Constant-2 set of IgSF domains
The members here are composed of the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILRs) and Natural killer inhibitory receptors (KIRs, also known as also known as cluster of differentiation (CD) 158), and similar proteins. This group includes LILRB1 (also known as LIR-1), LILRA5 (also known as LIR9), an activating natural cytotoxicity receptor NKp46, the immune-type receptor glycoprotein VI (GPVI), and the IgA-specific receptor Fc-alphaRI (also known as cluster of differentiation (CD) 89). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3, and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1, LILRB2 (also known as LIR-2), and LILRB3 (also known as LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs), it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LILRB1, and LILRB2, show detectable binding to class I MHC molecules; ligands for the other members have yet to be determined. The extracellular portions of the different LIR proteins contain different numbers of Ig-like domains for example, four in the case of LILRB1, and LILRB2, and two in the case of LILRB4 (also known as LIR-5). The activating natural cytotoxicity receptor NKp46 is expressed in natural killer cells, and is organized as an extracellular portion having two Ig-like extracellular domains, a transmembrane domain, and a small cytoplasmic portion. GPVI, which also contains two Ig-like domains, participates in the processes of collagen-mediated platelet activation and arterial thrombus formation. Fc-alphaRI is expressed on monocytes, eosinophils, neutrophils, and macrophages; it mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Killer cell immunoglobulin-like receptors (KIRs; also known as CD158 for human KIR) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. KIRs are a family of highly polymorphic activating and inhibitory receptors that serve as key regulators of human NK cell function. The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The major ligands for KIR are MHC class I (HLA-A, -B or -C) molecules.
Statistics
?
PSSM-Id: 409409
Aligned: 9 rows
Threshold Bit Score: 122.552
Created: 12-Sep-2007
Updated: 25-Oct-2021
Structure
?
Program:
Drawing:
Aligned Rows:
  next features
Conserved site includes 3 residues -Click on image for an interactive view with Cn3D
Feature 1:putative ligand binding site [chemical binding site]
Evidence:
  • Comment:Ligand binding site is predicted by site directed mutagenesis.

Sequence Alignment
?
Format: Row Display: Color Bits: Type Selection:
Feature 1                                      #                                         #    
2D3V_A      5 KATLWAEPGSVISRGNSVTIRCQGTLEAQEYRLVKegsp--epwDTQNplep--knkARFSIPSxtehHAGRYRCYYYsp 80  human
1OW0_C      7 MPFISAKSSPVIPLDGSVKIQCQAIREAYLTQLMIiknstyreiGRRLkfwn--etdPEFVIDHmdanKAGRYQCQYRig 84  human
2GI7_A      8 KPSLQALPSSLVPLEKPVTLRCQGPPGVDLYRLEKls-----ssRYQDq--------AVLFIPAmkrsLAGRYRCSYQng 74  human
1G0X_A      4 KPTLWAEPGSVITQGSPVTLRCQGGQETQEYRLYRekkt--apwITRIpqel--vkkGQFPIPSitweHAGRYRCYYGsd 79  human
1P6F_A      7 KPFIWAEPHFMVPKEKQVTICCQGNYGAVEYQLHFegs----lfAVDRpkpperinkVKFYIPDmnsrMAGQYSCIYRvg 82  human
1OLL_A      4 KPFIWAEPHFMVPKEKQVTICCQGNYGAVEYQLHFegs----lfAVDRpkpperinkVKFYIPDmnsrMAGQYSCIYRvg 79  Escherichia coli
BAD14958   28 IPIISAVPSSVIPLNESVKILCQGTPQSFLYQLEIlgn----stNKMVeekygfqkeAEFIINHmdtkTAGRYQCRYRka 103 horse
P04217     28 QPSLWAESESLLKPLANVTLTCQARLETPDFQLFKngv----aqEPVHldsp--aikHQFLLTGd---TQGRYRCRSGls 98  human
BAD08447   27 IPIISTATNPMVSWNESVRILCRGTPEAFLYQLSLmkn----stQTVIekklgfqkeAEFIINHmnstLAGCYQCQYRkk 102 Norway rat
Feature 1        #           
2D3V_A     81 -agWSEPSDPLELVV 94  human
1OW0_C     85 -hyRFRYSDTLELVV 98  human
2GI7_A     75 -slWSLPSDQLELVA 88  human
1G0X_A     80 tagRSESSDPLELVV 94  human
1P6F_A     83 -elWSEPSNLLDLVV 96  human
1OLL_A     80 -elWSEPSNLLDLVV 93  Escherichia coli
BAD14958  104 -yrWSKYSEALQLVV 117 horse
P04217     99 -tgWTQLSKLLELTG 112 human
BAD08447  103 -nhWSEQSKPLKLVV 116 Norway rat

| Disclaimer | Privacy statement | Accessibility |
NCBI Home NCBI Search NCBI SiteMap